The largest insider transaction on today's list is a Form 4 filing by Artal Group, which reported a purchase of roughly $40.4 million in Lexicon Pharmaceuticals $LXRX.

Artal Group now owns 83,835,950 LXRX shares, representing a roughly 47.5% ownership stake.

From the desk of Steve Strazza @Sstrazza

Welcome to our latest Minor Leaguers report.

We’ve had some great trades come out of this small-cap-focused column since we launched it back in 2020 and started rotating it with our flagship bottom-up scan, Under the Hood.

For the first year or so, we focused only on Russell 2000 stocks with a market cap between $1 and $2B.

That was fun, but we wanted to branch out a bit and allow some new stocks to find their way onto our list.

We expanded our universe to include some mid-caps.

To make the cut for our Minor Leaguers list, a company must have a market cap between $1 and $4B.

From the desk of Steve Strazza @sstrazza

This is one of our favorite bottom-up scans: Follow the Flow.

In this note, we simply create a universe of stocks that experienced the most unusual options activity — either bullish or bearish, but not both.

We utilize options experts, both internally and through our partnership with The TradeXchange. Then, we dig through the level 2 details and do all the work upfront for our clients.

Our goal is to isolate only those options market splashes that represent levered and high-conviction, directional bets.

We also weed out hedging activity and ensure there are no offsetting trades that either neutralize or cap the risk on these unusual options trades.

From the desk of Steve Strazza @Sstrazza

Our Top 10 Charts Report was just published.

In this weekly note, we highlight 10 of the most important charts or themes we're currently seeing in asset classes around the world.

Real Yields Roll in Favor of Gold

There has been plenty of evidence suggesting a significant breakdown in one of the world’s most critical inflationary assets, Gold. Miners look terrible, Silver and Platinum are weak, and the Silver/Gold ratio recently hit multi-year lows. These aren’t the type of data points that support higher gold prices. Real yields are another piece of evidence we can add to that list. The chart below shows the US 10-year real rate inverted and a chart of Gold. They look almost identical. Gold futures tend to trend lower when real rates rise (moving lower on the chart). Despite every reason to break down, Gold has remained resilient. And now, as many of the negative data points mentioned above begin to reverse, including real yields, a rally in gold could ensue. 

From the desk of Steve Strazza @Sstrazza

Check out this week's Momentum Report, our weekly summation of all the major indexes at a Macro, International, Sector, and Industry Group level.

By analyzing the short-term data in these reports, we get a more tactical view of the current state of markets. This information then helps us put near-term developments into the big picture context and provides insights regarding the structural trends at play.

Let's jump right into it with some of the major takeaways from this week's report:

* ASC Plus Members can access the Momentum Report by clicking the link at the bottom of this post.

Macro Universe:

CD&R Investment Associates disclosed the purchase of approximately $6 million worth of Beacon Roofing Supply $BECN in a Form 4 on Friday.

The firm now owns 24,348,048 shares, which represents a roughly 35% ownership stake in the mid-cap building products company.

From the desk of Steve Strazza @Sstrazza

Our Hall of Famers list is composed of the 150 largest US-based stocks.

These stocks range from the mega-cap growth behemoths like Apple and Microsoft – with market caps in excess of $2T – to some of the new-age large-cap disruptors such as Moderna, Square, and Snap.

It has all the big names and more.

It doesn’t include ADRs or any stock not domiciled in the US. But don’t worry; we developed a separate universe for that which you can check out here.

The Hall of Famers is simple.

We take our list of 150 names and then apply our technical filters so the strongest stocks with the most momentum rise to the top.

Let’s dive right in and check out what these big boys are up to.

Here’s this week’s list:

From the Desk of Steve Strazza @Sstrazza

As this summer’s relief rally gains momentum, the new highs list is gaining and growing along with it.

For long-only universes like The Hot List, this is great news.

Why?

Because we finally have a good amount of bullish chart setups to choose from again. For a few months there, we were struggling to find solid opportunities for putting on long exposure.

We’ve been patiently waiting for evidence that the market is turning. And while we’re not out of the woods yet, conditions have improved significantly since June.

Let’s dive in and talk about some health care stocks that have our attention right now. 

Insiders are buying up regional banks this week.

Independent Director Robert Stallings reported an additional  purchase of $1.2 million in Texas Capital Bancshares $TCB, as he continues to build his position.

The president and CEO of Heritage-Crystal Clean $HCCI reported a purchase of 150,000 shares, roughly equivalent to $4,000,000 worth of stock.

The only 13D on our list today was filed by Inclusive Capital Partners LP.

From the Desk of Steve Strazza @Sstrazza

When investing in the stock market, we always want to approach it as "a market of stocks."

Regardless of the environment, there are always stocks showing leadership and trending higher.

We may have to look harder to identify them depending on current market conditions. But there are always stocks that are going up.

The same can be said for weak stocks. Regardless of the environment, there are always stocks that are going down, too. 

We already have multiple scans focusing on stocks making all-time highs, such as Hall of Famers, Minor Leaguers, and the 2 to 100 Club.

We filter these universes for stocks that are exhibiting the best momentum and relative strength characteristics. 

Clearly, we spend a lot of time identifying and writing about leading stocks every week, via multiple reports.

Now, we're also highlighting lagging stocks on a recurring basis.

Welcome to the Short Report.

This is the video recording of our July 27, 2022, Inside Scoop Weekly Strategy Session.